Omar Alhalabi, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Topic:
    Research (institutional)
    Date added:
    06/20/2023
    Date updated:
    07/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Arcus
    Topic:
    Research (institutional)
    Date added:
    06/20/2023
    Date updated:
    07/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Ikena
    Topic:
    Research (institutional)
    Date added:
    06/20/2023
    Date updated:
    07/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech
    Topic:
    Research (institutional)
    Date added:
    06/20/2023
    Date updated:
    07/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Seagen
    Topic:
    Advisory board
    Date added:
    06/20/2023
    Date updated:
    07/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Silverback
    Topic:
    Advisory board
    Date added:
    06/20/2023
    Date updated:
    07/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Cardinal health
    Topic:
    Advisory board
    Date added:
    06/20/2023
    Date updated:
    07/10/2024
Return to BTF's 2024 Updates on Hematology and Oncology, Houston